Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
364
-
Total 13F shares, excl. options
-
120M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$7.08B
-
Value change
-
+$119M
-
Put/Call ratio
-
0.97
-
Number of buys
-
163
-
Number of sells
-
-161
-
Price
-
$58.96
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q2 2020
422 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q2 2020.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 364 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120M shares
of 159M outstanding shares and own 75.78% of the company stock.
Largest 10 shareholders include FMR LLC (20.8M shares), VANGUARD GROUP INC (12.3M shares), BlackRock Inc. (8.65M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.61M shares), Bellevue Group AG (8.25M shares), BAILLIE GIFFORD & CO (8.22M shares), Clearbridge Investments, LLC (7.66M shares), STATE STREET CORP (3.59M shares), Invesco Ltd. (2.34M shares), and WADDELL & REED FINANCIAL INC (2.17M shares).
This table shows the top 364 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.